The changing face of Crohn’s disease: a population-based study of the natural history of Crohn’s disease in Örebro, Sweden 1963–2005
暂无分享,去创建一个
[1] S. Hanauer,et al. Treat to target: a proposed new paradigm for the management of Crohn's disease. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[2] J. Halfvarson,et al. Temporal trends in non-stricturing and non-penetrating behaviour at diagnosis of Crohn's disease in Örebro, Sweden: a population-based retrospective study. , 2014, Journal of Crohn's & colitis.
[3] F. Dias de Castro,et al. Tailoring Crohn's disease treatment: the impact of small bowel capsule endoscopy. , 2014, Journal of Crohn's & colitis.
[4] M. Vatn,et al. Early anti-TNF treatment in pediatric Crohn’s disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients , 2014, Scandinavian journal of gastroenterology.
[5] J. Andrews,et al. Early Use of Thiopurines or Methotrexate Reduces Major Abdominal and Perianal Surgery in Crohn's Disease , 2014, Inflammatory bowel diseases.
[6] P. Munkholm,et al. Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy , 2014, The American Journal of Gastroenterology.
[7] A. Majeed,et al. The Impact of Timing and Duration of Thiopurine Treatment on First Intestinal Resection in Crohn's Disease: National UK Population-Based Study 1989–2010 , 2014, The American Journal of Gastroenterology.
[8] T. Cars,et al. P622 Health care consumption and treatment of Crohn's disease in Stockholm County , 2014 .
[9] S. Saxena,et al. The Role of Thiopurines in Reducing the Need for Surgical Resection in Crohn's Disease: A Systematic Review and Meta-Analysis , 2014, The American Journal of Gastroenterology.
[10] Subrata Ghosh,et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. , 2013, Gastroenterology.
[11] G. Rogler,et al. Diagnostic Delay in Crohn's Disease Is Associated With a Complicated Disease Course and Increased Operation Rate , 2013, The American Journal of Gastroenterology.
[12] M. Sans,et al. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease. , 2013, Gastroenterology.
[13] J. Mary,et al. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. , 2013, Gastroenterology.
[14] J. Wohlfahrt,et al. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011 , 2013, Gut.
[15] E. Louis. Strategic Use of Immunosuppressants and Anti-TNF in Inflammatory Bowel Disease , 2013, Digestive Diseases.
[16] H. Sokol,et al. 555 What Is the Prognosis of Silent Crohn's Disease ? , 2013 .
[17] L. Dauchet,et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study , 2013, Gut.
[18] G. Veres,et al. Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977–2009 , 2012, The American Journal of Gastroenterology.
[19] S. Ng,et al. Hospitalisations and surgery in Crohn's disease , 2012, Gut.
[20] C. Bernstein,et al. Outcomes of patients with Crohn's disease improved from 1988 to 2008 and were associated with increased specialist care. , 2011, Gastroenterology.
[21] L. Biancone,et al. Small bowel capsule endoscopy vs conventional techniques in patients with symptoms highly compatible with Crohn's disease. , 2011, Journal of Crohn's & colitis.
[22] L. Peyrin-Biroulet,et al. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease , 2011, Gut.
[23] A. Zinsmeister,et al. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. , 2010, Gastroenterology.
[24] Geraint T. Williams,et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates , 2010, Gut.
[25] P. Rutgeerts,et al. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. , 2008, Gastroenterology.
[26] M. Vatn,et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[27] P. Munkholm,et al. Increasing Incidences of Inflammatory Bowel Disease and Decreasing Surgery Rates in Copenhagen City and County, 2003–2005: A Population-Based Study from the Danish Crohn Colitis Database , 2006, The American Journal of Gastroenterology.
[28] M. Pochapin,et al. Asymptomatic ileitis: past, present, and future. , 2006, Journal of clinical gastroenterology.
[29] J. Satsangi,et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[30] L. Beaugerie,et al. Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery , 2005, Gut.
[31] M. Russel,et al. Has disease outcome in Crohn's disease changed during the last four decades? , 2004, Alimentary pharmacology & therapeutics.
[32] Samir A. Shah,et al. Risk of early surgery for Crohn's disease: implications for early treatment strategies , 2003, American Journal of Gastroenterology.
[33] R. McLeod. Surgery for Inflammatory Bowel Diseases , 2003, Digestive Diseases.
[34] V. Fazio,et al. Evolution of surgery for Crohn's disease , 1999, Diseases of the colon and rectum.
[35] G. D'Haens,et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. , 1999, Gastroenterology.
[36] R. McLeod,et al. Quality of Life of Patients with Inflammatory Bowel Disease after Surgery , 1998, World Journal of Surgery.
[37] P. Munkholm,et al. Intestinal cancer risk and mortality in patients with Crohn's disease. , 1993, Gastroenterology.
[38] D. Sachar,et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. , 1988, Gut.
[39] R. Farmer,et al. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. , 1985, Gastroenterology.
[40] H. Mekhjian,et al. Clinical features and natural history of Crohn's disease. , 1979, Gastroenterology.
[41] G. Hellers. Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. , 1979, Acta chirurgica Scandinavica. Supplementum.
[42] R. Farmer,et al. Indications for surgery in Crohn's disease: analysis of 500 cases. , 1976, Gastroenterology.
[43] A. Peña,et al. Course and prognosis of Crohn's disease. , 1976, Gut.